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Introduction 
Although the majority of patients with 
pheochromocytoma have hypertension, 5-
15% of patients are normotensive and this 
percentage may be higher in patients with 
adrenal “incidentalomas”.1-3  The diagnosis 
of asymptomatic pheochromocytoma is 
increasing in incidence, most likely due to 
widespread use of sectional imaging.4 The 
most reliable method for diagnosing 
pheochromocytoma or paraganglioma is 
measurement of 24-hour urine catechol-
amines and metanephrines, with a sensitivity 
and specificity of roughly 98%.5-7 The 
urinary vanillylmandelic acid level though 
may retain some value in the diagnosis of 
pheochromocytoma, particularly when 
paired with characteristic findings on 
imaging. 
 
Case Report 
A 68-year-old male underwent computed 
tomography (CT) of the abdomen as part of 
a work-up for back pain and an 
unintentional 20 pound (9 kg) weight loss 
over the previous six months.  The scan 
revealed a right-sided adrenal mass 1.8 cm 
in maximum dimension.  A follow-up CT 
scan after six months showed an increase in 
the size of the mass to 2.2 x 1.8 cm, with a 
non-contrast attenuation value of 13 
Hounsfield units (HU).  The mass was noted 
to have an irregular border.   CT scanning of  
 
 
the chest was performed and demonstrated 
no evidence of other masses or adenopathy. 
The patient denied fevers, flushing, 
palpitations, abdominal pain, or other 
constitutional symptoms.  He was a previous 
smoker, with roughly a 30 pack-year history. 
Physical examination and vital signs 
were normal.  Laboratory revealed a normal 
random serum cortisol of 7 mcg/dl.  A 24-
hour urine collection for catecholamines and 
metanephrines was within normal limits, 
with total metanephrines of 772 mcg/24 
hours (normal range 224-832 mcg/24 hours) 
and catecholamines of 55 mcg/24 hours 
(normal range 26-121 mcg/24 hours).  The 
24-hour urine vanillylmandelic acid (VMA) 
was elevated minimally at 9 mg/24 hours 
(normal range <9 mg/24 hours).  Because of 
the patient’s weight loss and the history of 
tobacco abuse, he was scheduled for 
laparoscopic surgical resection of the mass 
with malignancy high in the differential 
diagnosis. 
Intraoperatively, the patient developed 
tachycardia of 140 beats per minute and 
hypertension, with a systolic blood pressure 
exceeding 260 mm Hg.  He was given IV 
metoprolol and nitroglycerin with good 
results.   
Pathology revealed a 1.5 cm tumor 
located in the adrenal medulla and 
compressing  the  adrenal  cortex,  consistent  
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with a pheochromocytoma.  Low mitotic 
activity was noted.  Neither tumor necrosis 
nor invasion into the periadrenal tissue was 
noted.     Subsequent    laboratory    analysis, 
including a calcitonin level, was normal. 
The patient recovered without incident 
and was discharged on no antihypertensives 
the day following surgery. 
 
 
 
Figure 1.  A 1.5 cm tumor located in the adrenal medulla and compressing the adrenal cortex, 
consistent with a pheochromocytoma 
 
Discussion 
Pheochromocytoma may be present in 
up to five percent of all patients with an 
adrenal incidentaloma.7 Imaging charac-
teristics typically help to differentiate 
between pheochromocytoma and adrenal 
adenoma.  A Hounsfield attenuation value 
less than 10 HU on unenhanced CT 
scanning typically is associated with a 
benign cortical adenoma.  A value of greater 
than 10 HU is associated with malignancy, 
pheochromocytoma, and less commonly 
adenoma (roughly 30 percent of adenomas 
do not have a large lipid content).9 
Contrast washout may help differentiate 
between adenomas and nonadenomas.10  
Typically, adenomas are associated with 
rapid (> 50 percent at 10 minutes) contrast 
material washout in contrast-enhanced CT, 
 
 
whereas carcinomas or pheochromocytomas  
are associated with delayed (< 50 percent at 
10 minutes) contrast material washout.  
Beside the patient’s slightly elevated 
urinary VMA and moderately high pre-
contrast attenuation, little in our patient 
suggested the presence of a pheochromo-
cytoma.  The indication for surgery was 
suspicion for malignancy.   
The urinary VMA has fallen out of favor 
as a routine test for pheochromocytoma.  
The elevated urinary VMA, though, should 
have changed management of this patient, as 
it has been shown to have a specificity of 96 
percent for the presence of a pheochromo-
cytoma.  It is limited by its poor sensitivity 
of 76 percent.11  
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Conclusions 
We depend on history, physical exam, 
laboratory, and radiological characteristics 
to diagnose pheochromocytoma, but 
sometimes the definitive diagnosis is 
regrettably established by pathology.  The 
patient’s history of weight loss led to the 
discovery of the neoplasm, but did not 
prompt the examiners to consider 
 
pheochromocytoma highly on their 
differential diagnosis.  Closer attention to 
detail in this case, namely, notation of the 
relatively high attenuation of the lesion in 
combination with the elevated urinary 
VMA, may have led to appropriate alpha 
blockade and thus prevented an 
intraoperative hypertensive emergency. 
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